Publications

Found 7 results
Author Title Type [ Year(Desc)]
Filters: Author is Mertlíková-Kaiserová, Helena  [Clear All Filters]
2021
Břehová, P.; Česnek, M.; Dračínský, M.; Chaloupecká, E.; Janeba, Z.; Mertlíková-Kaiserová, H.; Skácel, J.; Soto-Velasquez, M. P.; Tloušťová, E.; Watts, V. J. Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases. European Journal of Medicinal Chemistry 2021, 222 (October 15 2021), nestránkováno.
2022
Bouřa, E.; Dejmek, M.; Chalupská, D.; Klíma, M.; Matoušová, M.; Mertlíková-Kaiserová, H.; Misehe, M.; Nencka, R.; Šála, M. Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold. Bioorganic and Medicinal Chemistry Letters 2022, 76 (November), nestránkováno.
2023
Skácel, J.; Djukic, S.; Baszczyňski, O.; Kalčic, F.; Bílek, T.; Chalupský, K.; Kozák, J.; Dvořáková, A.; Tloušťová, E.; Kráľová, Z.; et al. Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors. Journal of Medicinal Chemistry 2023, 66 (10), 6652-6681.
Misehe, M.; Matoušová, M.; Dvořáková, A.; Hercík, K.; Škach, K.; Chalupská, D.; Dejmek, M.; Šála, M.; Hájek, M.; Bouřa, E.; et al. Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinases. European Journal of Medicinal Chemistry 2023, 260 (November).
Štefek, M.; Chalupská, D.; Chalupský, K.; Zgarbová, M.; Dvořáková, A.; Krafčíková, P.; Li, A. Shi Ming; Šála, M.; Dejmek, M.; Otava, T.; et al. Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors. ACS Omega 2023, 8 (30), 27410-27418.
2024
Misehe, M.; Šála, M.; Matoušová, M.; Hercík, K.; Kocek, H.; Chalupská, D.; Chaloupecká, E.; Hájek, M.; Bouřa, E.; Mertlíková-Kaiserová, H.; et al. Design, synthesis and evaluation of novel thieno[2,3d]pyrimidine derivatives as potent and specific RIPK2 inhibitors. Bioorganic and Medicinal Chemistry Letters 2024, 97 (1 January 2024).
Kocek, H.; Chalupská, D.; Dejmek, M.; Dvořáková, A.; Zgarbová, M.; Šála, M.; Chalupský, K.; Krafčíková, P.; Otava, T.; Drexler, M.; et al. Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides. RSC Medicinal Chemistry 2024, nestránkováno.
xs sm md lg